{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:22:26Z","timestamp":1780582946985,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.carrev.2016.02.012","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T13:56:21Z","timestamp":1456667781000},"page":"162-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation"],"prefix":"10.1016","volume":"17","author":[{"given":"Giampaolo","family":"Niccoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Marchitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco A.","family":"Montone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fracassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Grippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Burzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Trani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Di Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Speranza","family":"Rubattu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.02.012_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.02.012_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.02.012_bb0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.02.012_bb0020","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2016.02.012_bb0025","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4065\/mcp.2011.0437","article-title":"Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study","volume":"86","author":"McKie","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.carrev.2016.02.012_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/eurheartj\/ehs239","article-title":"N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS","volume":"34","author":"Welsh","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.02.012_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijcard.2011.07.077","article-title":"Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort","volume":"152","author":"Barbato","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal proB-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"Kragelund","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.02.012_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2011.11.057","article-title":"NT-proANP circulating level is a prognostic marker in stable ischemic heart disease","volume":"155","author":"Barbato","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.111.063842","article-title":"Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease","volume":"125","author":"Sabatine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.012_bb0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/CS20040087","article-title":"N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction","volume":"107","author":"Squire","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.carrev.2016.02.012_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/2047487314538856","article-title":"MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI","volume":"22","author":"Lindberg","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0065","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2006.05.056","article-title":"Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy","volume":"48","author":"James","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.113.004420","article-title":"Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization","volume":"129","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.012_bb0075","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.02.012_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2009.01.033","article-title":"Role of cardiac natriuretic peptides in human coronary atherosclerosis","volume":"206","author":"Barbato","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2016.02.012_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/002215540205000606","article-title":"Natriuretic peptide system gene expression in human coronary arteries","volume":"50","author":"Casco","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.carrev.2016.02.012_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jgm.2639","article-title":"Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery","volume":"14","author":"Larifla","year":"2012","journal-title":"J Gene Med"},{"key":"10.1016\/j.carrev.2016.02.012_bb0095","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.ijcard.2012.12.046","article-title":"Diagnostic implication of change in b-type natriuretic peptide (BNP) for prediction of subsequent target lesion revascularization following sirorimus-eluting stent deployment","volume":"168","author":"Hasumi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jjcc.2011.01.015","article-title":"Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation","volume":"57","author":"Masaki","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2143\/AC.63.1.2025331","article-title":"Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention","volume":"63","author":"Yildirir","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/hrt.2003.018051","article-title":"Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary intervention","volume":"90","author":"Kalra","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2016.02.012_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00019501-200608000-00004","article-title":"Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization","volume":"17","author":"Palazzuoli","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2016.02.012_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.4960230412","article-title":"Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty","volume":"23","author":"Kyriakides","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(98)00342-8","article-title":"N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty","volume":"68","author":"Klinge","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1474651409344927","article-title":"A new use for B-type natriuretic peptide: to detect myocardial ischemia in non-heart failure patients","volume":"10","author":"Noman","year":"2010","journal-title":"Br J Diab Vasc Dis"},{"key":"10.1016\/j.carrev.2016.02.012_bb0135","doi-asserted-by":"crossref","first-page":"H1388","DOI":"10.1152\/ajpheart.00414.2002","article-title":"Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro","volume":"284","author":"Kook","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.carrev.2016.02.012_bb0140","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI114893","article-title":"Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells","volume":"86","author":"Hiroshi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carrev.2016.02.012_bb0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1172\/JCI117402","article-title":"Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth","volume":"94","author":"Morishita","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carrev.2016.02.012_bb0150","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCULATIONAHA.105.580233","article-title":"Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.02.012_bb0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajh.2008.174","article-title":"Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases","volume":"21","author":"Rubattu","year":"2008","journal-title":"Am J Hypertens"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916300495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916300495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:10:56Z","timestamp":1761559856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916300495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1553838916300495"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.02.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}